193 related articles for article (PubMed ID: 22383227)
1. Effect of gender on late-onset multiple sclerosis.
Bove RM; Healy B; Augustine A; Musallam A; Gholipour T; Chitnis T
Mult Scler; 2012 Oct; 18(10):1472-9. PubMed ID: 22383227
[TBL] [Abstract][Full Text] [Related]
2. Is late-onset multiple sclerosis associated with a worse outcome?
Tremlett H; Devonshire V
Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
[TBL] [Abstract][Full Text] [Related]
3. Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.
Guillemin F; Baumann C; Epstein J; Kerschen P; Garot T; Mathey G; Debouverie M;
Neuroepidemiology; 2017; 48(3-4):179-187. PubMed ID: 28793296
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study.
Mouresan EF; Mentesidou E; Berglund A; McKay KA; Hillert J; Iacobaeus E
Neurology; 2024 Mar; 102(6):e208051. PubMed ID: 38394472
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis.
Mirmosayyeb O; Brand S; Barzegar M; Afshari-Safavi A; Nehzat N; Shaygannejad V; Sadeghi Bahmani D
J Clin Med; 2020 May; 9(5):. PubMed ID: 32370288
[TBL] [Abstract][Full Text] [Related]
6. Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
Alroughani R; Akhtar S; Ahmed S; Behbehani R; Al-Hashel J
PLoS One; 2016; 11(11):e0165846. PubMed ID: 27802328
[TBL] [Abstract][Full Text] [Related]
7. Late-onset multiple sclerosis in Isfahan, Iran.
Etemadifar M; Abtahi SH; Minagar A; Akbari M; Masaeli A; Tabrizi N
Arch Iran Med; 2012 Oct; 15(10):596-8. PubMed ID: 23020533
[TBL] [Abstract][Full Text] [Related]
8. Cognition and disease characteristics in adult onset versus late onset multiple sclerosis.
Butler Pagnotti R; Hua LH; Miller JB
Mult Scler; 2022 May; 28(6):933-941. PubMed ID: 34410177
[TBL] [Abstract][Full Text] [Related]
9. Clinical profile and HLA-DRB1 genotype of late onset multiple sclerosis in Western Australia.
Qiu W; Wu JS; Castley A; James I; Joseph J; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
J Clin Neurosci; 2010 Aug; 17(8):1009-13. PubMed ID: 20580995
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
El-Salem K; Khader Y
Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328
[TBL] [Abstract][Full Text] [Related]
11. Late onset multiple sclerosis.
Arias M; Dapena D; Arias-Rivas S; Costa E; López A; Prieto JM; Corredera E
Neurologia; 2011 Jun; 26(5):291-6. PubMed ID: 21163234
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment.
Shirani A; Zhao Y; Petkau J; Gustafson P; Karim ME; Evans C; Kingwell E; van der Kop ML; Oger J; Tremlett H
Biomed Res Int; 2015; 2015():451912. PubMed ID: 25922836
[TBL] [Abstract][Full Text] [Related]
13. Late-onset MS is associated with an increased rate of reaching disability milestones.
Andersen MA; Buron MD; Magyari M
J Neurol; 2021 Sep; 268(9):3352-3360. PubMed ID: 33677675
[TBL] [Abstract][Full Text] [Related]
14. Late onset multiple sclerosis: concerns in aging patients.
Lotti CBC; Oliveira ASB; Bichuetti DB; Castro I; Oliveira EML
Arq Neuropsiquiatr; 2017 Jul; 75(7):451-456. PubMed ID: 28746432
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a late-onset multiple sclerosis Portuguese cohort.
Moura J; Duarte S; Oliveira V; Pereira D; Costa D; Samões R; Sousa AP; Silva AM; Santos E
Mult Scler Relat Disord; 2023 Feb; 70():104506. PubMed ID: 36638770
[TBL] [Abstract][Full Text] [Related]
16. Course and prognosis in early-onset MS: comparison with adult-onset forms.
Simone IL; Carrara D; Tortorella C; Liguori M; Lepore V; Pellegrini F; Bellacosa A; Ceccarelli A; Pavone I; Livrea P
Neurology; 2002 Dec; 59(12):1922-8. PubMed ID: 12499484
[TBL] [Abstract][Full Text] [Related]
17. Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics.
Ghadiri F; Sahraian MA; Razazian N; Ashtari F; Poursadeghfard M; Nabavi SM; Navardi S; Baghbanian SM; Shaygannejad V; Harirchian MH; Beladimoghadam N; Majdinasab N; Hosseini S; Azimi A; Kamali H; Sharifipour E; Hosseini Nejad Mir N; Bayati A; Nahayati MA; Heidari H; Mozhdehipanah H; Ghalyanchi Langroodi H; Jalali N; Ayoubi S; Asadollahzadeh E; Ebadi Z; Eskandarieh S; Naser Moghadasi A
Mult Scler Relat Disord; 2023 Feb; 70():104493. PubMed ID: 36638768
[TBL] [Abstract][Full Text] [Related]
18. Disability progression in multiple sclerosis is slower than previously reported.
Tremlett H; Paty D; Devonshire V
Neurology; 2006 Jan; 66(2):172-7. PubMed ID: 16434648
[TBL] [Abstract][Full Text] [Related]
19. The natural history of primary progressive multiple sclerosis.
Koch M; Kingwell E; Rieckmann P; Tremlett H
Neurology; 2009 Dec; 73(23):1996-2002. PubMed ID: 19996074
[TBL] [Abstract][Full Text] [Related]
20. Comparing the Pathology, Clinical, and Demographic Characteristics of Younger and Older-Onset Multiple Sclerosis.
Knowles S; Middleton R; Cooze B; Farkas I; Leung YY; Allen K; Winslade M; Owen DRJ; Magliozzi R; Reynolds R; Neal JW; Pearson O; Nicholas R; Pickrell WO; Howell OW;
Ann Neurol; 2024 Mar; 95(3):471-486. PubMed ID: 38061895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
